Annual Book Value
-$62.46 M
-$66.35 M-81.44%
31 December 2023
Summary:
Galectin Therapeutics annual book value is currently -$62.46 million, with the most recent change of -$66.35 million (-81.44%) on 31 December 2023. During the last 3 years, it has fallen by -$84.41 million (-384.66%). GALT annual book value is now -244.14% below its all-time high of $43.34 million, reached on 31 December 2019.GALT Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
-$94.70 M
-$10.33 M-12.25%
30 September 2024
Summary:
Galectin Therapeutics quarterly book value is currently -$94.70 million, with the most recent change of -$10.33 million (-12.25%) on 30 September 2024. Over the past year, it has dropped by -$41.60 million (-78.33%). GALT quarterly book value is now -291.86% below its all-time high of $49.36 million, reached on 30 June 2019.GALT Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.4% | -78.3% |
| 3 y3 years | -384.7% | -1453.1% |
| 5 y5 years | -2956.0% | -300.6% |
GALT Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -384.7% | at low | -1453.1% | at low |
| 5 y | 5 years | -244.1% | at low | -300.6% | at low |
| alltime | all time | -244.1% | at low | -291.9% | at low |
Galectin Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$94.70 M(+12.2%) |
| June 2024 | - | -$84.37 M(+15.1%) |
| Mar 2024 | - | -$73.31 M(+17.4%) |
| Dec 2023 | -$62.46 M(+81.4%) | -$62.46 M(+17.6%) |
| Sept 2023 | - | -$53.11 M(-0.5%) |
| June 2023 | - | -$53.36 M(+18.9%) |
| Mar 2023 | - | -$44.88 M(+30.4%) |
| Dec 2022 | -$34.43 M(-9506.3%) | -$34.43 M(+40.1%) |
| Sept 2022 | - | -$24.57 M(+40.7%) |
| June 2022 | - | -$17.46 M(+106.8%) |
| Mar 2022 | - | -$8.44 M(-2406.8%) |
| Dec 2021 | $366.00 K(-98.3%) | $366.00 K(-94.8%) |
| Sept 2021 | - | $7.00 M(-52.9%) |
| June 2021 | - | $14.87 M(-7.0%) |
| Mar 2021 | - | $15.98 M(-27.2%) |
| Dec 2020 | $21.94 M(-49.4%) | $21.94 M(-25.1%) |
| Sept 2020 | - | $29.29 M(-15.7%) |
| June 2020 | - | $34.75 M(-14.2%) |
| Mar 2020 | - | $40.49 M(-6.6%) |
| Dec 2019 | $43.34 M(-2220.1%) | $43.34 M(-8.2%) |
| Sept 2019 | - | $47.22 M(-4.3%) |
| June 2019 | - | $49.36 M(+977.3%) |
| Mar 2019 | - | $4.58 M(-324.2%) |
| Dec 2018 | -$2.04 M(-73.7%) | -$2.04 M(<-9900.0%) |
| Sept 2018 | - | $18.00 K(-97.8%) |
| June 2018 | - | $823.00 K(-113.0%) |
| Mar 2018 | - | -$6.31 M(-18.7%) |
| Dec 2017 | -$7.77 M(-354.5%) | -$7.77 M(+23.5%) |
| Sept 2017 | - | -$6.29 M(+100.1%) |
| June 2017 | - | -$3.15 M(-567.3%) |
| Mar 2017 | - | $673.00 K(-78.0%) |
| Dec 2016 | $3.05 M(-82.5%) | $3.05 M(-17.1%) |
| Sept 2016 | - | $3.68 M(-46.9%) |
| June 2016 | - | $6.93 M(-41.8%) |
| Mar 2016 | - | $11.91 M(-31.8%) |
| Dec 2015 | $17.48 M(-15.2%) | $17.48 M(+42.4%) |
| Sept 2015 | - | $12.28 M(-29.1%) |
| June 2015 | - | $17.31 M(-18.7%) |
| Mar 2015 | - | $21.28 M(+3.2%) |
| Dec 2014 | $20.63 M(+2207.4%) | $20.63 M(-8.9%) |
| Sept 2014 | - | $22.65 M(-10.0%) |
| June 2014 | - | $25.16 M(-9.1%) |
| Mar 2014 | - | $27.68 M(+2996.1%) |
| Dec 2013 | $894.00 K(+67.7%) | $894.00 K(+33.8%) |
| Sept 2013 | - | $668.00 K(-118.0%) |
| June 2013 | - | -$3.72 M(+123.1%) |
| Mar 2013 | - | -$1.67 M(-412.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $533.00 K(-119.3%) | $533.00 K(-78.0%) |
| Sept 2012 | - | $2.42 M(-43.3%) |
| June 2012 | - | $4.27 M(-31.0%) |
| Mar 2012 | - | $6.19 M(-324.6%) |
| Dec 2011 | -$2.76 M(+17.9%) | -$2.76 M(-1543.5%) |
| Sept 2011 | - | $191.00 K(-32.5%) |
| June 2011 | - | $283.00 K(-136.1%) |
| Mar 2011 | - | -$784.00 K(-66.5%) |
| Dec 2010 | -$2.34 M(-54.4%) | -$2.34 M(-32.7%) |
| Sept 2010 | - | -$3.47 M(-3.0%) |
| June 2010 | - | -$3.58 M(-44.4%) |
| Mar 2010 | - | -$6.44 M(+25.4%) |
| Dec 2009 | -$5.13 M(+337.4%) | -$5.13 M(+7.7%) |
| Sept 2009 | - | -$4.76 M(+17.9%) |
| June 2009 | - | -$4.04 M(+43.9%) |
| Mar 2009 | - | -$2.81 M(+139.3%) |
| Dec 2008 | -$1.17 M(-59.9%) | -$1.17 M(+7.9%) |
| Sept 2008 | - | -$1.09 M(-23.3%) |
| June 2008 | - | -$1.42 M(-63.4%) |
| Mar 2008 | - | -$3.87 M(+32.3%) |
| Dec 2007 | -$2.92 M(>+9900.0%) | -$2.92 M(+66.9%) |
| Sept 2007 | - | -$1.75 M(-359.6%) |
| June 2007 | - | $675.00 K(+36.6%) |
| Mar 2007 | - | $494.00 K(-2345.5%) |
| Dec 2006 | -$22.00 K(-100.6%) | -$22.00 K(-246.7%) |
| Sept 2006 | - | $15.00 K(-100.7%) |
| June 2006 | - | -$2.03 M(-43.5%) |
| Mar 2006 | - | -$3.60 M(-200.3%) |
| Dec 2005 | $3.58 M(-64.5%) | $3.58 M(-32.7%) |
| Sept 2005 | - | $5.33 M(-24.0%) |
| June 2005 | - | $7.00 M(-19.5%) |
| Mar 2005 | - | $8.70 M(-13.9%) |
| Dec 2004 | $10.11 M(+32.5%) | $10.11 M(-17.3%) |
| Sept 2004 | - | $12.22 M(+44.3%) |
| June 2004 | - | $8.47 M(+44.7%) |
| Mar 2004 | - | $5.85 M(-23.2%) |
| Dec 2003 | $7.62 M(+371.7%) | $7.62 M(+60.5%) |
| Sept 2003 | - | $4.75 M(+165.4%) |
| June 2003 | - | $1.79 M(-20.6%) |
| Mar 2003 | - | $2.25 M(+39.4%) |
| Dec 2002 | $1.62 M(+32.9%) | $1.62 M(+38.7%) |
| Sept 2002 | - | $1.17 M(+242.8%) |
| June 2002 | - | $339.90 K(-34.1%) |
| Mar 2002 | - | $515.60 K(-57.6%) |
| Dec 2001 | $1.22 M | $1.22 M(+150.4%) |
| Sept 2001 | - | $485.60 K(-170.3%) |
| June 2001 | - | -$690.60 K |
FAQ
- What is Galectin Therapeutics annual book value?
- What is the all time high annual book value for Galectin Therapeutics?
- What is Galectin Therapeutics annual book value year-on-year change?
- What is Galectin Therapeutics quarterly book value?
- What is the all time high quarterly book value for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly book value year-on-year change?
What is Galectin Therapeutics annual book value?
The current annual book value of GALT is -$62.46 M
What is the all time high annual book value for Galectin Therapeutics?
Galectin Therapeutics all-time high annual book value is $43.34 M
What is Galectin Therapeutics annual book value year-on-year change?
Over the past year, GALT annual book value has changed by -$28.04 M (-81.44%)
What is Galectin Therapeutics quarterly book value?
The current quarterly book value of GALT is -$94.70 M
What is the all time high quarterly book value for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly book value is $49.36 M
What is Galectin Therapeutics quarterly book value year-on-year change?
Over the past year, GALT quarterly book value has changed by -$41.60 M (-78.33%)